NCT00570570

Brief Summary

Gait impairment remain one of the main problem for hemiplegic stroke patients. After the 6 first months, stroke patients are classically described with moderate or no improvement. Here, we want to compare the effectiveness of a flexor and extensor paretic knee muscular strengthening program with conventional physiotherapy delivered by the local physiotherapist of the patient, in a very ecological way.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
91

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2008

Longer than P75 for not_applicable

Geographic Reach
1 country

5 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 7, 2007

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 11, 2007

Completed
5 months until next milestone

Study Start

First participant enrolled

May 1, 2008

Completed
5.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2013

Completed
Last Updated

August 20, 2015

Status Verified

August 1, 2015

Enrollment Period

5.6 years

First QC Date

December 7, 2007

Last Update Submit

August 19, 2015

Conditions

Keywords

strokehemiplegiagaitStrengtheningPhysiotherapy

Outcome Measures

Primary Outcomes (1)

  • Gait comfortable speed

    3 months

Secondary Outcomes (1)

  • gait analysis (gait maximal speed, kymographic and dynamometric analysis, quality of gait parameter) FIM MOS-SF36 Spasticity (Tardieu Scale)

    3 months

Study Arms (2)

group 1

OTHER

Muscular Strengthening for paretic knee flexor and extensor

Procedure: Muscular Strengthening for paretic knee flexor and extensor

group 2

ACTIVE COMPARATOR

conventional physiotherapy

Other: conventional physiotherapy

Interventions

thrice a week during 6 weeks

group 1

trice a week during 6 weeks

group 2

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Hemipegia due to ischaemic or hemorrhagic stroke more than 6 months ago
  • st and unique cerebral lesion (Xscan or MRI)
  • ability to walk 15 m with or without cane or crutch
  • able to understand and give approved consent
  • quadriceps at 3/5 (MRC) or stronger

You may not qualify if:

  • Current treatment with botulinum toxin for spasticity of the paretic flexor or extensor of the knee
  • Cardiovascular disease contra-indicating effort and strengthening
  • Pregnancy
  • Evolving pathology
  • Rheumatic disease of the knee contraindicating strengthening
  • Aphasia with severe comprehension impairment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

Centre Mutualiste de Rééducation Fonctionnelle, rue Angély Cavlié

Albi, 81000, France

Location

Service de Médecine Physique et de Réadaptation, Hôpital Pellegrin, CHU de Bordeaux,

Bordeaux, 33076, France

Location

Service de Médecine Physique et de Réadaptation, Hôpital Jean Rebeyrol, CHU de Limoges,

Limoges, 87042 cedex, France

Location

Service de Médecine Physique et de Réadaptation, Hôpital de Salies du Salat

Salies-du-Salat, 31260, France

Location

Service de Médecine Physique et de Réadaptation, Hôpital Rangueil, CHU de Toulouse, TSA 50032

Toulouse, 31059, France

Location

MeSH Terms

Conditions

HemiplegiaStroke

Condition Hierarchy (Ancestors)

ParalysisNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Xavier D de Boissezon

    University Hospital, Toulouse

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 7, 2007

First Posted

December 11, 2007

Study Start

May 1, 2008

Primary Completion

December 1, 2013

Study Completion

December 1, 2013

Last Updated

August 20, 2015

Record last verified: 2015-08

Locations